Trials / Completed
CompletedNCT00004938
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID) · NIH
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
OBJECTIVE: I. Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral sporotrichosis.
Detailed description
PROTOCOL OUTLINE: Patients are treated with daily oral fluconazole for up to 24 months. Follow-up continues for at least 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluconazole |
Timeline
- Start date
- 1996-08-01
- Completion
- 1996-08-01
- First posted
- 2000-02-25
- Last updated
- 2006-06-09
Source: ClinicalTrials.gov record NCT00004938. Inclusion in this directory is not an endorsement.